Belite Bio, Inc Deferred Tax Assets, Operating Loss Carryforwards
Belite Bio, Inc (BLTE) had Deferred Tax Assets, Operating Loss Carryforwards of $17.41 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.41M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.67M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.56M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.40M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $17.41M 20-F · filed 2026-03-31 |
| 2024-12-31 | $9.67M 20-F · filed 2026-03-31 |
| 2023-12-31 | $5.56M 20-F · filed 2025-03-17 |
| 2022-12-31 | $2.40M 20-F · filed 2024-03-12 |
| 2021-12-31 | $1.27M 20-F · filed 2023-03-31 |